IV ports and syringe tips are exposed, easily contaminated, and implicated in contributing to healthcare-associated infections (HAI). A WHO study showed 7-15% of hospitalized patients acquire an HAI; 10% of these patients die each year. The CDC states certain HAIs cost $13 billion and cause 99,000 deaths annually.
DoubleLock Healthcare, Inc™ has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ to address this costly HAI issue, delivering 100% IV port and syringe tip asepsis.
View Demonstration Video